Los Angeles Capital Management
KRRO icon

Los Angeles Capital Management’s Korro Bio KRRO Stock Holding History

Los Angeles Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-110
Closed -$4.01K – 2519
2025
Q4 		$4.01K Buy
+110
New +$2.57K ﹤0.01% 2325

Other funds holding KRRO

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Los Angeles Capital Management's KRRO Position: Q1 2026 in Review

Los Angeles Capital Management sold out of Korro Bio (KRRO) in Q1 2026, closing a stake of 110 shares — an estimated $4.01K sold.

Los Angeles Capital Management first reported a position in KRRO in Q4 2025 and held it in 1 quarter. The position peaked at $4.01K in Q4 2025. 99 funds tracked by Wall St. Rank hold KRRO as of Q1 2026.

  • Los Angeles Capital Management reported no remaining Korro Bio position as of Q1 2026 after selling out during the quarter.
  • Los Angeles Capital Management sold 110 Korro Bio shares in Q1 2026, an estimated $4.01K.
  • Los Angeles Capital Management first reported a position in Korro Bio in Q4 2025 and held it in 1 quarter.
  • Los Angeles Capital Management's Korro Bio position peaked at $4.01K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Korro Bio as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.